National Biotechnology Initiative Act of 2025

# National Biotechnology Initiative Act of 2025 - Plain Language Summary **What the Bill Would Do:** The National Biotechnology Initiative Act of 2025 would establish a coordinated federal effort to advance biotechnology research and development in the United States. While specific provisions aren't detailed in the available information, bills with this title typically aim to increase funding, coordinate efforts across federal agencies, and strengthen America's competitiveness in the biotechnology field—an industry involving genetic engineering, drug development, and biological research. **Who It Affects:** This legislation would primarily affect researchers and institutions receiving federal funding, biotech companies, pharmaceutical developers, and potentially patients who benefit from new biotechnology-based treatments. It may also impact federal agencies involved in scientific research and economic competitiveness, and could influence U.S. standing in the global biotech market. **Current Status:** As of now, the bill (S 1387) is in committee, meaning it's under review and hasn't yet advanced to a full Senate vote.

It was introduced by Senator Todd Young, a Republican from Indiana. The bill remains in the early stages of the legislative process. *Note: Complete details about specific provisions aren't available in the summary provided. For full information, consult Congress.gov.*.